Skip to main content
NatCon25 Main banner

    Substance Use Continuum of Care

    Systems and Models of Care

    K6 - Altered States, New Outcomes: Psychedelic Therapies for SUD

    Wednesday, May 7, 2025
    10:30 AM - 11:30 AM ET
    Location: 105AB
    NASW CCB ACCME ANCC APA NY-MHC NADAAC NBCC NY-SW
    As the understanding of psychedelics grows, therapies involving substances like ibogaine, ketamine, and psilocybin are transforming the treatment of substance use disorders (SUD). This session will explore how these groundbreaking therapies are being used to address addiction by promoting neural plasticity, healing trauma, and offering new pathways for recovery.

    Join our expert panel as they delve into the science behind psychedelic-assisted treatments, the clinical protocols involved, and the challenges of integrating these therapies into modern care. Panelists will also discuss patient experiences, ethical considerations, and the importance of supportive care structures for maximizing outcomes.

    Whether you’re curious about the potential of psychedelics or already navigating this innovative space, this session will provide a comprehensive look at how altered states can unlock new possibilities for healing.

    Learning Objectives:

    • Explore new therapies that are improving SUD care.
    • Examine the data behind psychedelic therapies.
    • Identify the protocols clinicians are using to integrate psychedelic therapies into treatment plans.